Author:
Mehran Roxana,Cao Davide,Angiolillo Dominick J.,Bangalore Sripal,Bhatt Deepak L.,Ge Junbo,Hermiller James,Makkar Raj R.,Neumann Franz-Josef,Saito Shigeru,Picon Hector,Toelg Ralph,Maksoud Aziz,Chehab Bassem M.,De la Torre Hernandez Jose M.,Kunadian Vijay,Sardella Gennaro,Thiele Holger,Varenne Olivier,Vranckx Pascal,Windecker Stephan,Zhou Yujie,Krucoff Mitchell W.,Ruster Karine,Wang Jin,Valgimigli Marco
Subject
Cardiology and Cardiovascular Medicine
Reference33 articles.
1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016
2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
3. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients;Palmerini;Eur Heart J,2017
4. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial;Mehran;Eur Heart J,2009
5. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial;Valgimigli;Eur Heart J,2017
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献